Insider Holders & Insider Ownership - PROGENICS PHARMACEUTICALS INC (PGNX)

List of insiders holdings for PROGENICS PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Velan Capital L.P.
Altiva Management Inc.
VENKATARAMAN BALAJI
See Explanation of Responses
10% Owner		2020-04-15 15:15:288,011,733
0		8,011,733Form 13D
LTE Partners LLC
Melkonian Capital Management LLC
LTE Management LLC
Melkonian Ryan
See Explanation of Responses
10% Owner		2019-09-09 18:14:161,950,000
0		1,950,000Form 4
MADDON PAUL J
Director		2016-04-22 17:09:42909,891
0		909,891Form 4/A
Baker Mark Robert
Chief Executive Officer		2019-03-05 15:49:30192,500
0		192,500Form 4
JACOBSON PAUL F
Director		2008-10-24 16:34:22125,600
0		125,600Form 4
Nohria Virinder
See Explanation of Responses
10% Owner		2019-08-27 15:39:59110,000
0		110,000Form 3
Summer Jeffery
SVP, Digital Technology		2018-03-02 13:57:3794,875
0		94,875Form 4
Hirt Sheldon
Executive VP & General Counsel		2016-03-03 14:34:1382,500
0		82,500Form 4
Fabbio Patrick
CFO		2020-03-04 16:15:0282,214
0		82,214Form 4
Boyd Thomas A
Sr. VP, Product Dev.		2010-07-06 14:16:3379,436
0		79,436Form 4
Youssoufian Hagop
Executive Vice President R&D		2014-03-04 15:32:5166,000
0		66,000Form 4
Olson William C
Senior VP, Research and Develo		2013-04-08 15:58:0060,000
0		60,000Form 4
Crowley Peter J
Director		2019-07-15 09:01:3955,000
0		55,000Form 4
Lovallo Angelo William JR
Vice President Finance		2015-03-04 11:27:3352,800
0		52,800Form 4
MCKINNEY ROBERT A
Senior VP, CFO		2012-03-05 14:23:5850,000
0		50,000Form 4
YACHMETZ PHILIP K
VP, General Counsel		2004-05-05 17:18:2340,696
200		40,896Form 4
Cooke Terence
See Explanation of Responses
10% Owner		2019-08-27 15:25:1540,000
0		40,000Form 3
ISRAEL ROBERT J
Executive Vice President, Medi		2015-06-15 09:32:3739,050
0		39,050Form 4
PRENTKI RONALD J
President		2005-02-17 18:27:5835,672
0		35,672Form 4
Kremer Alton B
VP, Clinical Research		2008-04-03 17:09:5728,173
0		28,173Form 4
KISHBAUCH MICHAEL D
Director		2019-07-15 09:02:0325,000
0		25,000Form 4
WILLIAMS NICOLE
Director		2019-07-15 09:02:3325,000
0		25,000Form 4
SCHEINBERG DAVID A
Director		2019-07-15 09:02:2125,000
0		25,000Form 4
GOFF STEPHEN P
Director		2013-06-20 15:43:2720,000
0		20,000Form 4
BAKER CHARLES A
Director		2012-06-14 14:57:1510000
0		10000Form 4
BRINER KURT W
Director		2012-06-14 14:56:4510000
0		10000Form 4
DALTON MARK F
Director		2011-07-06 19:01:1710000
0		10000Form 4
Ferrante Karen Jean
Director		2020-06-23 16:47:070
0		0Form 4
Das Asha
Chief Medical Officer		2020-06-23 16:49:430
0		0Form 4
Osorio Benedict
COO		2020-06-23 16:49:250
0		0Form 4
Tenbarge Bryce
SVP, Commercial		2020-06-23 16:49:040
0		0Form 4
Wong Vivien
EVP, Development		2020-06-23 16:48:470
0		0Form 4
Mims David W.
Interim CEO and Interim CFO		2020-06-23 16:48:250
0		0Form 4
Ber Gerard
Director		2020-06-23 16:48:050
0		0Form 4
Campbell Bradley L
Director		2020-06-23 16:47:460
0		0Form 4
Ende Eric J
Director		2020-06-23 16:47:260
0		0Form 4
MacDougall Ann L.
Director		2020-06-23 16:46:470
0		0Form 4
Maeusli Heinz Christoph
Director		2020-06-23 16:46:240
0		0Form 4
Sarpangal Deepak
See Explanation of Responses
10% Owner		2019-08-27 15:29:070
0		0Form 3
Broadfin Healthcare Master Fund Ltd
Broadfin Capital LLC
KOTLER KEVIN
10% Owner		2018-02-13 16:57:520
0		0Form 13G